Blue Jet Healthcare Limited
ListedMainboardIndustrial & Financial Services · NSE / BSE
Incorporated in 1968, Blue Jet Healthcare is a science-led pharmaceutical company specializing in healthcare ingredients and intermediates. The company was the first in India to manufacture saccharin and its salts and has since expanded into contrast media intermediates for CT scans and MRIs. Its main product categories include contrast media intermediates, high-intensity sweeteners, and pharmaceutical intermediates and APIs. Blue Jet Healthcare offers process development, production capabilities, global regulatory support, and collaboration in advanced pharmaceutical development. The company operates three manufacturing facilities in Shahad, Ambernath, and Mahad, Maharashtra, with annual installed capacities of 200.60 KL, 607.30 KL, and 213.00 KL, respectively, as of June 30, 2023.
Price Band
₹329 – ₹346
Issue Size
₹840 Cr
Lot Size
43 shares
GMP
₹22
+6.4%
Est. Listing
₹368
at current GMP
Subscribed
7.94x
overall
Open
25 Oct 2023
Close
27 Oct 2023
Allotment
30 Oct 2023
Refund
31 Oct 2023
Demat Credit
1 Nov 2023
Listing
1 Nov 2023
Last updated 12 days ago
Official Registrar Verification
Blue Jet Healthcare Limited Allotment Status
Designated Registrar: Link Intime India Private Limited
Allotment Date
30 Oct 2023
Basis finalization
Refunds Initiate
31 Oct 2023
Mandate release
Demat Credit
1 Nov 2023
Shares in demat
Listing Debut
1 Nov 2023
Trading begins
How to Check Blue Jet Healthcare Limited IPO Allotment Status
- Click the Check on Registrar button above to visit Link Intime India Private Limited's allotment portal.
- Select Blue Jet Healthcare Limited from the dropdown company list.
- Choose your lookup mode: PAN Number, Application Number, or DP Client ID.
- Enter your details accurately and solve the Captcha code.
- Click Submit / Search to view the number of shares applied and allotted to you.
About Blue Jet Healthcare Limited Public Issue & Market Profile
Blue Jet Healthcare Limited is bringing an initial public offering (IPO) in the Industrial & Financial Services sector with an aggregate issue size of ₹840.27 Crores. The shares are offered at a price band of ₹329 to ₹346 per equity share on NSE and BSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.
Public Issue & Allotment Procedure:
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Official Allotment Timelines & Registrar Guidance:
Following the close of bidding on 2023-10-27, the basis of allotment is scheduled to be finalized on 2023-10-30. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Link Intime India Private Limited) or the BSE allotment checking window.
Frequently Asked Questions
What if my name is not showing on the registrar portal?
Allotment records are updated in batches. If the status is not yet available, please wait a few hours until the basis of allotment is fully finalized.
How will I receive the refund if I don't get allotment?
Since funds are blocked under ASBA/UPI, the bank will automatically release the blocked hold on your funds upon receipt of revocation instructions from the sponsor bank.